Evaluation of type I interferon pathway in KRAS-driven lung adenocarcinoma and its potential synergy with immunotherapy

Información

Fecha: 06/07/2023
Hora 10:00
Lugar: Auditorio CNIO
Conferenciante Fernando Fernández García
Procedencia Experimental Oncology Group, Molecular Oncology Programme
Supervised by Director Mariano Barbacid and co-director Monica Musteanu, Experimental Oncology Group Molecular Oncology Programme
Entrada libre hasta completar aforo